(HealthDay)—A minimally invasive surgery to treat chronic heartburn is safer than generally believed, and could be a desirable alternative to long-term use of acid reflux medications, new research indicates.
Mar 30, 2016
0
25
The use of proton pump inhibitors, the popular medications used to treat gastroesophageal reflux and peptic ulcers, may be associated with an increased risk of dementia in a study using data from a large German health insurer, ...
Feb 15, 2016
0
10
A type of heartburn medication called proton pump inhibitors (PPIs) may be linked to long-term kidney damage, according to a new study published in JAMA Internal Medicine.
Jan 18, 2016
0
8
Proton pump inhibitors (PPIs), which are commonly used drugs to reduce acid in the stomach, appear to be associated with an increased risk of chronic kidney disease but more research is needed to determine whether PPI use ...
Jan 11, 2016
0
24
(HealthDay)—About half of patients with symptomatic esophageal eosinophilia have clinicohistologic remission with proton pump inhibitor (PPI) therapy, according to a review published in the January issue of Clinical Gastroenterology ...
Jan 8, 2016
0
0
Proton pump inhibitors (PPIs), commonly used for heartburn and gastric distress, should be prescribed at the lowest dose possible and for the shortest length of time because of potential side effects, according to a review ...
Nov 23, 2015
0
30
(HealthDay)—Chronic proton pump inhibitor (PPI) exposure is associated with mild hyperparathyroidism in elderly adults, according to a study published in the October issue of the Journal of the American Geriatrics Society.
Nov 3, 2015
0
4
Certain medications commonly used to treat heartburn and acid reflux may have damaging effects on the kidneys, according to two studies that will be presented at ASN Kidney Week 2015 November 3-8 at the San Diego Convention ...
Oct 27, 2015
0
30
Schistosomiasis is a neglected tropical disease caused by parasitic worms endemic in parts of Africa, Southeast Asia and Central and South America. It is currently treated by the drug praziquantel which, while both effective ...
Sep 24, 2015
0
4
(HealthDay)—For patients taking dabigatran, the risk of gastrointestinal bleeding (GIB) is reduced with use of gastroprotective agents, according to a study published in the September issue of Gastroenterology.
Aug 31, 2015
0
5
